Breckenridge Pharmaceutical Receives FDA Approval for Injection
Breckenridge Pharmaceutical Receives Final FDA Approval
Breckenridge Pharmaceutical, Inc. has received exciting news from the U.S. Food and Drug Administration: the agency has granted final approval for its Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) Multi-Dose Vial. This development is a significant milestone for the company, which is a U.S. subsidiary of Towa International.
Indications for Methadone Hydrochloride Injection
The Methadone Hydrochloride Injection is indicated for two primary uses: first, for managing severe and persistent pain that necessitates extended treatment with an opioid analgesic when alternative therapies have failed. Secondly, it serves as a temporary treatment option for opioid dependence in individuals who cannot take oral medications.
Strategic Growth in Healthcare
This latest launch aligns perfectly with Breckenridge's strategic vision to broaden its reach in the institutional healthcare sector. The company is committed to enhancing its product portfolio, which now includes advancements in Oncology, Autoimmune disorders, Rare Diseases, and Supportive Care. These initiatives illustrate Breckenridge's focus on addressing critical healthcare needs while fostering innovation.
Vision of Holistic Health
Breckenridge's dedication to expanding its pharmaceutical offerings reflects its adherence to Towa International's holistic health vision. This approach encompasses various aspects of well-being, including physical, mental, and emotional health, resonating with the comprehensive definition of health put forth by the World Health Organization.
Insights from Leadership
Brian Guy, President and CCO, expressed the company's commitment by saying, "By integrating our product range within the institutional measures, we significantly improve our capacity to address the industry's healthcare challenges with precision and effectiveness. This bold move demonstrates our commitment to adapting to the healthcare professional's evolving needs, thereby enhancing patient care outcomes."
About Breckenridge Pharmaceutical
Located in New Jersey, Breckenridge Pharmaceutical, Inc. partners with worldwide manufacturers to deliver high-quality, cost-effective generic pharmaceuticals. The company's commitment to customer service and on-time delivery fosters positive impacts on the health of patients throughout the United States.
Contact Information
For additional inquiries, please reach out to:
Towa International / Breckenridge Pharmaceutical, Inc.
Rosa Horri, External Communications and Investor Relations
Website: www.breckenridgepharma.com
Frequently Asked Questions
What is Methadone Hydrochloride Injection used for?
Methadone Hydrochloride Injection is primarily used to manage severe pain and as a temporary treatment for opioid dependence.
How does Breckenridge Pharmaceutical plan to expand its product range?
The company aims to enhance its institutional channel offerings and introduce new products across various medical fields.
What does the approval from the FDA signify?
FDA approval confirms that Breckenridge's Methadone Hydrochloride Injection meets stringent regulatory standards for safety and efficacy.
Who is the President of Breckenridge Pharmaceutical?
Brian Guy serves as the President and Chief Commercial Officer of Breckenridge Pharmaceutical.
Where is Breckenridge Pharmaceutical located?
Breckenridge Pharmaceutical, Inc. is based in New Jersey, serving as the U.S. subsidiary of Towa International.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.